Diagnosis of SAHH requires a combination of clinical performance, imaging, laboratory testing, and pathology. The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of SAHH deficiencies require the development of individualized treatment regimens, typically including drug therapy, rehabilitation interventions, and regular follow-up management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic diseases have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the lack of SAHH.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.